X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-07-11 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $20.18 | -740 | 77,142 | -1% | -$14,933 | ||||||
2023-06-13 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $19.27 | -8,868 | 106,038 | -8% | -$170,886 | ||||||
2023-06-13 | INSM | Adsett Roger | COO | S - Sale | $19.32 | -8,981 | 151,352 | -6% | -$173,513 | ||||||
2023-05-25 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $18.95 | -3,366 | 102,681 | -3% | -$63,786 | ||||||
M | 2023-05-15 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $18.44 | -2,887 | 106,047 | -3% | -$53,224 | |||||
M | 2023-05-15 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $18.77 | -3,635 | 77,082 | -5% | -$68,214 | |||||
M | 2023-05-15 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale | $18.62 | -5,019 | 93,525 | -5% | -$93,438 | |||||
M | 2023-05-15 | INSM | Lewis William | Chair, CEO | S - Sale | $18.58 | -16,861 | 575,269 | -3% | -$313,312 | |||||
M | 2023-05-15 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $18.94 | -4,294 | 114,906 | -4% | -$81,328 | |||||
M | 2023-05-15 | INSM | Bonstein Sara | CFO | S - Sale | $18.95 | -3,820 | 117,619 | -3% | -$72,390 | |||||
M | 2023-05-15 | INSM | Adsett Roger | COO | S - Sale | $18.66 | -6,816 | 160,333 | -4% | -$127,191 | |||||
2023-05-15 | INSM | Sharoky Melvin Md | Dir | P - Purchase | $19.29 | +20,000 | 342,458 | +6% | +$385,800 | ||||||
2023-01-10 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $17.96 | -779 | 77,272 | -1% | -$13,991 | ||||||
2023-01-10 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $17.93 | -1,836 | 54,332 | -3% | -$32,919 | ||||||
2023-01-10 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale | $17.95 | -2,435 | 72,159 | -3% | -$43,708 | ||||||
2023-01-10 | INSM | Lewis William | Chair, CEO | S - Sale | $18.00 | -6,994 | 265,067 | -3% | -$125,892 | ||||||
2023-01-10 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $18.06 | -3,439 | 72,763 | -5% | -$62,108 | ||||||
2023-01-10 | INSM | Bonstein Sara | CFO | S - Sale | $18.12 | -2,857 | 66,031 | -4% | -$51,769 | ||||||
2023-01-10 | INSM | Adsett Roger | COO | S - Sale | $17.99 | -3,194 | 135,487 | -2% | -$57,460 | ||||||
D | 2023-01-05 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale+OE | $19.74 | -1,160 | 78,051 | -1% | -$22,898 | |||||
D | 2023-01-05 | INSM | Smith Michael Alexander | GC, SVP | S - Sale+OE | $19.72 | -720 | 56,168 | -1% | -$14,198 | |||||
D | 2023-01-05 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $19.73 | -1,448 | 74,594 | -2% | -$28,569 | |||||
D | 2023-01-05 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $19.80 | -7,008 | 272,061 | -3% | -$138,758 | |||||
D | 2023-01-05 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale+OE | $19.73 | -1,374 | 76,202 | -2% | -$27,109 | |||||
D | 2023-01-05 | INSM | Adsett Roger | COO | S - Sale+OE | $19.75 | -3,044 | 138,681 | -2% | -$60,119 | |||||
2022-11-22 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $18.84 | -7,154 | 71,613 | -9% | -$134,781 | ||||||
2022-11-22 | INSM | Adsett Roger | COO | S - Sale | $18.80 | -11,855 | 134,127 | -8% | -$222,874 | ||||||
M | 2022-10-31 | INSM | Sharoky Melvin Md | Dir | P - Purchase | $17.59 | +30,000 | 301,552 | +11% | +$527,600 | |||||
2022-10-31 | INSM | Lee Leo | Dir | P - Purchase | $17.69 | +45,000 | 98,265 | +84% | +$796,050 | ||||||
2022-08-10 | INSM | Wise John Drayton | Chief Commercial Officer | S - Sale | $27.79 | -258 | 78,767 | 0% | -$7,170 | ||||||
D | 2022-08-08 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $27.84 | -216,800 | 256,716 | -46% | -$6,035,570 | |||||
2022-07-12 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $23.40 | -941 | 50,455 | -2% | -$22,019 | ||||||
D | 2022-07-07 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $23.00 | -96,614 | 256,716 | -27% | -$2,222,122 | |||||
M | 2022-05-16 | INSM | Adsett Roger | COO | S - Sale | $19.57 | -3,416 | 145,982 | -2% | -$66,847 | |||||
2022-05-16 | INSM | Bonstein Sara | CFO | S - Sale | $18.51 | -1,433 | 54,683 | -3% | -$26,525 | ||||||
2022-05-16 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $18.51 | -1,574 | 66,432 | -2% | -$29,135 | ||||||
M | 2022-05-16 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale | $19.53 | -2,784 | 68,822 | -4% | -$54,360 | |||||
M | 2022-05-16 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $19.82 | -1,488 | 50,583 | -3% | -$29,492 | |||||
M | 2022-05-16 | INSM | Lewis William | Chair, CEO | S - Sale | $19.52 | -9,394 | 255,828 | -4% | -$183,353 | |||||
2022-05-11 | INSM | Sharoky Melvin Md | Dir | P - Purchase | $17.20 | +20,000 | 265,652 | +8% | +$344,000 | ||||||
D | 2022-03-23 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $23.16 | -96,614 | 217,624 | -31% | -$2,238,022 | |||||
2022-01-11 | INSM | Lewis William | Chair, CEO | S - Sale | $25.11 | -2,873 | 217,624 | -1% | -$72,141 | ||||||
2022-01-11 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $25.11 | -407 | 37,426 | -1% | -$10,220 | ||||||
2022-01-11 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale | $25.11 | -925 | 56,961 | -2% | -$23,227 | ||||||
2022-01-12 | INSM | Adsett Roger | COO | S - Sale | $24.58 | -1,217 | 121,938 | -1% | -$29,914 | ||||||
2022-01-11 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $25.11 | -1,495 | 46,038 | -3% | -$37,539 | ||||||
2022-01-11 | INSM | Bonstein Sara | CFO | S - Sale | $25.11 | -1,154 | 35,979 | -3% | -$28,977 | ||||||
M | 2022-01-05 | INSM | Adsett Roger | COO | S - Sale | $27.02 | -4,827 | 105,420 | -4% | -$130,441 | |||||
M | 2022-01-05 | INSM | Lewis William | Chair, CEO | S - Sale | $26.92 | -12,463 | 189,756 | -6% | -$335,511 | |||||
2022-01-05 | INSM | Flammer Martina M.D. | Chief Medical Officer | S - Sale | $27.61 | -1,423 | 33,345 | -4% | -$39,289 | ||||||
M | 2022-01-05 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale | $26.78 | -3,115 | 48,428 | -6% | -$83,410 | |||||
M | 2022-01-05 | INSM | Smith Michael Alexander | GC, SVP | S - Sale | $27.06 | -1,136 | 28,375 | -4% | -$30,742 | |||||
DM | 2021-12-23 | INSM | Lewis William | Chair, CEO | S - Sale+OE | $27.97 | -96,614 | 202,219 | -32% | -$2,702,606 | |||||
D | 2021-11-01 | INSM | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S - Sale+OE | $30.28 | -61,000 | 51,514 | -54% | -$1,847,352 | |||||
2021-11-01 | INSM | Brennan David R | Dir | P - Purchase | $30.15 | +10,000 | 80,876 | +14% | +$301,500 | ||||||
2021-11-01 | INSM | Engelsen Steinar J | Dir | P - Purchase | $30.14 | +14,235 | 320,802 | +5% | +$429,043 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |